English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Community

+ Community
Amanda Rupp | Sep 10, 2016

Astellas broadens medical and development communications staff

+ Regulatory
Amanda Rupp | Sep 10, 2016

Moonshot panel outlines approach for fight against cancer

+ Community
Amanda Rupp | Sep 10, 2016

Heart association study shows exercise could decrease medical costs

+ Regulatory
Amanda Rupp | Sep 10, 2016

EC approves Bristol-Myers Squibb's rheumatoid arthritis treatment ORENCIA

+ Regulatory
Amanda Rupp | Sep 10, 2016

Bipartisan leaders strive for MACRA success

+ Technology/Innovation
Amanda Rupp | Sep 10, 2016

Benralizumab Phase III trials have positive results for severe asthma

+ Regulatory
Amanda Rupp | Sep 10, 2016

FDA releases final rule for efficacy and safety of antibacterial soaps

+ Technology/Innovation
LocalLabs News Service | Sep 10, 2016

Heart disease risk may rise with gallstone disease

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 433
  • 434
  • 435
  • 436
  • 437
  • 438
  • 439
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily